Global Vaccines 麻豆原创 Research Report 2025

Publication ID:

PB505250748

Publication Date:

May 6, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Vaccines was valued at US$ 50450 million in the year 2024 and is projected to reach a revised size of US$ 73490 million by 2031, growing at a CAGR of 5.6% during the forecast period.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines.
The Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan
Segment by Type
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Segment by Application
Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Vaccines 麻豆原创 Overview
1.1 Product Definition
1.2 Vaccines by Type
1.2.1 Global Vaccines 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Vaccines by Application
1.3.1 Global Vaccines 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Rabies vaccine
1.3.3 Influenza vaccine
1.3.4 HPV vaccine
1.3.5 Hepatitis B
1.3.6 Hepatitis A
1.3.7 Leprosy vaccine
1.3.8 Polio vaccine
1.3.9 JE vaccine
1.3.10 Others
1.4 Global Vaccines 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Vaccines Revenue 2020-2031
1.4.2 Global Vaccines Sales 2020-2031
1.4.3 Global Vaccines 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vaccines 麻豆原创 Competition by Manufacturers
2.1 Global Vaccines Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Vaccines Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Vaccines, Date of Enter into This Industry
2.8 Global Vaccines 麻豆原创 Competitive Situation and Trends
2.8.1 Global Vaccines 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Vaccines Players 麻豆原创 Share by Revenue
2.8.3 Global Vaccines 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaccines 麻豆原创 Scenario by Region
3.1 Global Vaccines 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vaccines Sales by Region: 2020-2031
3.2.1 Global Vaccines Sales by Region: 2020-2025
3.2.2 Global Vaccines Sales by Region: 2026-2031
3.3 Global Vaccines Revenue by Region: 2020-2031
3.3.1 Global Vaccines Revenue by Region: 2020-2025
3.3.2 Global Vaccines Revenue by Region: 2026-2031
3.4 North America Vaccines 麻豆原创 Facts & Figures by Country
3.4.1 North America Vaccines 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vaccines Sales by Country (2020-2031)
3.4.3 North America Vaccines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vaccines 麻豆原创 Facts & Figures by Country
3.5.1 Europe Vaccines 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vaccines Sales by Country (2020-2031)
3.5.3 Europe Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccines 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Vaccines 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Vaccines 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Vaccines 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccines 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Vaccines 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccines Sales by Type (2020-2031)
4.1.1 Global Vaccines Sales by Type (2020-2025)
4.1.2 Global Vaccines Sales by Type (2026-2031)
4.1.3 Global Vaccines Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Vaccines Revenue by Type (2020-2031)
4.2.1 Global Vaccines Revenue by Type (2020-2025)
4.2.2 Global Vaccines Revenue by Type (2026-2031)
4.2.3 Global Vaccines Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vaccines Sales by Application (2020-2031)
5.1.1 Global Vaccines Sales by Application (2020-2025)
5.1.2 Global Vaccines Sales by Application (2026-2031)
5.1.3 Global Vaccines Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Vaccines Revenue by Application (2020-2031)
5.2.1 Global Vaccines Revenue by Application (2020-2025)
5.2.2 Global Vaccines Revenue by Application (2026-2031)
5.2.3 Global Vaccines Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Vaccines Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Vaccines Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Vaccines Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Vaccines Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Novartis(GSK)
6.5.1 Novartis(GSK) Company Information
6.5.2 Novartis(GSK) Description and Business Overview
6.5.3 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis(GSK) Vaccines Product Portfolio
6.5.5 Novartis(GSK) Recent Developments/Updates
6.6 CSL
6.6.1 CSL Company Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CSL Vaccines Product Portfolio
6.6.5 CSL Recent Developments/Updates
6.7 MedImmune LLC
6.7.1 MedImmune LLC Company Information
6.7.2 MedImmune LLC Description and Business Overview
6.7.3 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 MedImmune LLC Vaccines Product Portfolio
6.7.5 MedImmune LLC Recent Developments/Updates
6.8 J&J(Crucell)
6.8.1 J&J(Crucell) Company Information
6.8.2 J&J(Crucell) Description and Business Overview
6.8.3 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 J&J(Crucell) Vaccines Product Portfolio
6.8.5 J&J(Crucell) Recent Developments/Updates
6.9 China National Biotec
6.9.1 China National Biotec Company Information
6.9.2 China National Biotec Description and Business Overview
6.9.3 China National Biotec Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 China National Biotec Vaccines Product Portfolio
6.9.5 China National Biotec Recent Developments/Updates
6.10 Tiantan
6.10.1 Tiantan Company Information
6.10.2 Tiantan Description and Business Overview
6.10.3 Tiantan Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Tiantan Vaccines Product Portfolio
6.10.5 Tiantan Recent Developments/Updates
6.11 Hualan
6.11.1 Hualan Company Information
6.11.2 Hualan Description and Business Overview
6.11.3 Hualan Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hualan Vaccines Product Portfolio
6.11.5 Hualan Recent Developments/Updates
6.12 Kangtai
6.12.1 Kangtai Company Information
6.12.2 Kangtai Description and Business Overview
6.12.3 Kangtai Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Kangtai Vaccines Product Portfolio
6.12.5 Kangtai Recent Developments/Updates
6.13 Hissen
6.13.1 Hissen Company Information
6.13.2 Hissen Description and Business Overview
6.13.3 Hissen Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hissen Vaccines Product Portfolio
6.13.5 Hissen Recent Developments/Updates
6.14 Jintan
6.14.1 Jintan Company Information
6.14.2 Jintan Description and Business Overview
6.14.3 Jintan Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Jintan Vaccines Product Portfolio
6.14.5 Jintan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccines Industry Chain Analysis
7.2 Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccines Production Mode & Process Analysis
7.4 Vaccines Sales and 麻豆原创ing
7.4.1 Vaccines Sales Channels
7.4.2 Vaccines Distributors
7.5 Vaccines Customer Analysis
8 Vaccines 麻豆原创 Dynamics
8.1 Vaccines Industry Trends
8.2 Vaccines 麻豆原创 Drivers
8.3 Vaccines 麻豆原创 Challenges
8.4 Vaccines 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.